Correlation between cancer stem cells (CSCs) and tumor-infiltrating lymphocytes (TILs): do TILs interact with CSCs in non-small cell lung cancer?

被引：3
作者：
Ling, Min [1 ]
Yang, Xiaolong [1 ]
机构：
[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 15期
关键词：
RECURRENCE; SURVIVAL;
D O I：
10.21037/atm-20-1556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 13 条
[1]   Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity [J].
Cortes-Dericks, Lourdes ;
Froment, Laurene ;
Boesch, Ruben ;
Schmid, Ralph Alexander ;
Karoubi, Golnaz .
BMC CANCER, 2014, 14
[2]   Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer [J].
Feng, Wen ;
Li, Yuan ;
Shen, Lei ;
Cai, Xu-Wei ;
Zhu, Zheng-Fei ;
Chang, Jian-Hua ;
Xiang, Jia-Qing ;
Zhang, Ya-Wei ;
Chen, Hai-Quan ;
Fu, Xiao-Long .
ONCOTARGET, 2016, 7 (06) :7227-7240
[3]   Increased Levels of Tumor-Infiltrating Lymphocytes are Associated with Improved Recurrence-Free Survival in Stage 1A Non-Small-Cell Lung Cancer [J].
Horne, Zachary D. ;
Jack, Robert ;
Gray, Zachary T. ;
Siegfried, Jill M. ;
Wilson, David O. ;
Yousem, Samuel A. ;
Nason, Katie S. ;
Landreneau, Rodney J. ;
Luketich, James D. ;
Schuchert, Matthew J. .
JOURNAL OF SURGICAL RESEARCH, 2011, 171 (01) :1-5
[4]   Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer [J].
Huang, Zhaoqin ;
Yu, Haining ;
Zhang, Jianbo ;
Jing, Haiyan ;
Zhu, Wanqi ;
Li, Xiaolin ;
Kong, Lingling ;
Xing, Ligang ;
Yu, Jinming ;
Meng, Xiangjiao .
JOURNAL OF CANCER, 2017, 8 (16) :3190-3197
[5]   Density of Tumor-Infiltrating Lymphocytes Correlates with Disease Recurrence and Survival in Patients with Large Non-Small-Cell Lung Cancer Tumors [J].
Kilic, Arman ;
Landreneau, Rodney J. ;
Luketich, James D. ;
Pennathur, Arjun ;
Schuchert, Matthew J. .
JOURNAL OF SURGICAL RESEARCH, 2011, 167 (02) :207-210
[6]   Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer [J].
Kobayashi, Yoshie ;
Lim, Seung-Oe ;
Yamaguchi, Hirohito .
SEMINARS IN CANCER BIOLOGY, 2020, 65 :51-64
[7]   The Clinical Impact of Cancer Stem Cells [J].
Lathia, Justin ;
Liu, Huiping ;
Matei, Daniela .
ONCOLOGIST, 2020, 25 (02) :123-131
[8]   Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era [J].
Linette, Gerald P. ;
Carreno, Beatriz M. .
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (04) :286-291
[9]   Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study [J].
Masciale, Valentina ;
Grisendi, Giulia ;
Banchelli, Federico ;
D'Amico, Roberto ;
Maiorana, Antonino ;
Sighinolfi, Pamela ;
Pinelli, Massimo ;
Lovati, Eleonora ;
Stefani, Alessandro ;
Morandi, Uliano ;
Dominici, Massimo ;
Aramini, Beatrice .
ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
[10]  
Moharil Rohit Balwant, 2017, J Oral Maxillofac Pathol, V21, P463, DOI 10.4103/jomfp.JOMFP_132_16
12